Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RAD011
- Development stage
- Unknown
- Lead developer
- Radius Health
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
RAD011 is a pharmaceutical-grade synthetic cannabidiol (CBD) oral solution developed for the treatment of hyperphagia and related neuro-behavioral symptoms in Prader-Willi syndrome (PWS). It is manufactured using traditional pharmaceutical processes to ensure high purity and consistency. The drug is being investigated for its potential to reduce excessive appetite and improve irritability and overall behaviors in PWS patients. RAD011 has been assessed in over 150 patients across multiple indications and has potential utility in other neuro-endocrine or metabolic orphan diseases[4][5][6].
- Brand names
- Spectrum Therapeutics
- Other names
- Synthetic cannabidiol oral solutionCannabidiol oral solutionLab-made cannabidiol oral solution
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))CNR1 (Cannabinoid receptor 1)GPR55 (G protein-coupled receptor 55)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on RAD011.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RAD011.